antiviral agents Flashcards
what do antivirals target?
viral replication
what are good potential antiviral drugs?
Molecules that are virus encoded ofer potential virus-specific targets. This is notably the
case with viruses that have large genomes and code for their own replicative enzymes.
what is the main issue with using antivirals?
Therefore the most severe constraint limiting the use of antiviral drugs is not the lack of eficacy but he toxicity to the mammalian cel (por selective toxicity).
-viral replication is intimately associated with host replication
what defines a good antivirals
1.) successful antiviral drug should interfere with a virus-specific function (either because the function is unique to the virus or the similarhost function is much less
susceptible to the drug). Virus specific enzymes include proteases, mRNA caping enzyme, neuraminidases, ribonucleases, kinases, integrases, and uncoating enzymes
2.) successful antiviral drug should interfere with a virus-specific function (either because the function is unique to the virus or the similar host function is much less
susceptible to the drug). Virus specific enzymes include proteases, mRNA caping enzyme, neuraminidases, ribonucleases, kinases, integrases, and `uncoating enzymes
target therapeutic index
100-1000
- ratio of the minimum dose that is toxic to
host cels over the minimum dose that is toxic to the virus
ideally antiviral should
should be stable in the blood stream and easily taken by cells.
-They should also have as low toxicity as posible
successful antivirals
interferes with virus specific function or with a function for which the host target is less susceptible to the drug
what is virostatic
doesn’t kill virus
what does it mean that antivirals are virostatic?
must have an intact immune system to maintain the suppression of many viral infections
potential targets of drugs
- ) prevention of entry into host cells
- ) inhibition of virus uncoating
- ) integrase inhibitors
- ) duplication of viral genome
- ) mRNA transcription and processing
- ) protein translation
- ) post-translational modification of proteins
- ) assembly of molecular components into whole virus, maturation
- CCR5 co-receptor antagonist maraviroe
prevention of entry into host cells
- CCR5 co-receptor antagonist maraviroc
- can be used to treat in CCR5 tropic patients
- adjust dosage if combined with drugs that influence CYP enzymes
- one of the drugs being considered for preventive treatment against HIV infection
- exist non-competitive resistance by HIV: uses drug-bound form of CCR5 as a co-receptor
fusion inhibitors
Enfuvirtide
- inhibits HIV-specific gp-41 transmembrane glycoprotein
- used for patients not responding to current therapy
uncoating of virus consist of
loss of nucleocapside
what is noncompetitive resistance
when a virus learns to use a drug-bound form of receptor -example: maraviroc
when is un-coating pH-dependent?
at low pH, at level of endosomes or lysosomes
when is un-coating pH-independent?
when fusion with the plasma membrane
what is the best class of selective drugs available?
duplication of viral genome (RNA, DNA)
- act on duplication of viral genome, polymerases
- these drugs are mainly nucleoside analogs
why makes duplication drugs so selective?
- ) virus may use its own enzymes to activate the drug
2. ) viral polymerases are much more sensitive to drug than the corresponding host enzyme
what activates drugs in the duplication of viral genome class?
thymidine kinase encoded by some viruses-> used for synthesis of their DNA
- can activate certain drugs of this class
- leads to SELECTIVITY for infected cells only
what does the lack of selectivity for viral thymidine kinase allow?
allows nucleoside-analog drugs to be phosphorlyated like endogenous nucleosides
-enzyme of host cell have much greater specificity and it often does not phosphorylate the drug
why can nucleoside analogs enter the cell?
viral thymidine kinase can phosphorylate the nucleoside analogs permitting administration of drug in nonpohosphorylated form-> can enter cell better
how do nucleoside analog drugs cause chain termination?
-once the nucleoside analog is phosphorylated by thymidine kinase-> then by host cell’s enzymatic machinery-> formed into triphosphate compound-> incorporated into the growing nucleic acid chain-> leads to an irreversible association with viral polymerase and chain termination
nucleoside analog drugs
idoxuridine, cytarabine, vidarabine, ribavirin, acyclovir, ganciclovir, azidothimide
integrase inhibitor drugs
elvitegravir, dolutegravir, raltegravir (used to treat AIDS)
integrase inhibitors MOA
prevent insertion of virus genetic code into the DNA of infected cells by inhibiting the viral integrase
-Integrase strand transfer inhibitors-> used to treat AIDS
inhibition of un-coating drugs
arildone, plecoranil, amatidine, rimantidine